Microarray analysis of circulating microRNAs in familial Mediterranean fever

References

• Padeh S, Berkun Y. Familial Mediterranean fever. Curr Opin Rheumatol. 2016;28:523–9.
   PubMed Web of Science ®Google Scholar
• Manukyan G, Aminov R. Update on pyrin functions and mechanisms of familial Mediterranean fever. Front Microbiol. 2016;7:456.
   PubMed Web of Science ®Google Scholar
• Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever. Autoimmun Rev. 2014;13:388–90.
   PubMed Web of Science ®Google Scholar
• Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis. 2015;74:635–41.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101:2087–92.
   PubMed Web of Science ®Google Scholar
• Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 2013;12:1160–5.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.
   PubMed Web of Science ®Google Scholar
• Vigo G, Zulian F. Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev. 2012;12:52–5.
   PubMed Web of Science ®Google Scholar
• Tone Y, Toma T, Toga A, Sakakibara Y, Wada T, Yabe M, et al. Enhanced exon 2 skipping caused by c.910G > A variant and alternative splicing of MEFV genes in two independent cases of familial Mediterranean fever. Mod Rheumatol. 2012;22:45–51.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, et al. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One. 2012;7:e48366.
   PubMed Web of Science ®Google Scholar
• Taguchi YH, Murakami Y. Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PLoS One. 2013;8:e66714.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kubo S, Tamori A, Itami S, Kawamura E, Iwaisako K, et al. Comprehensive analysis of transcriptome and metabolome analysis in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci Rep. 2015;5:16294.
   PubMed Web of Science ®Google Scholar
• Taguchi YH, Murakami Y. Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases? BMC Res Notes. 2014;7:581.
   PubMedGoogle Scholar
• Tamori A, Murakami Y, Kubo S, Itami S, Uchida-Kobayashi S, Morikawa H, et al. MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy. Hepatol Res. 2016;46:E26–35.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Tanahashi T, Okada R, Toyoda H, Kumada T, Enomoto M, et al. Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray. PLoS One. 2014;9(9):e106314.
   PubMed Web of Science ®Google Scholar
• Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst. 2007;99:147–57.
   PubMed Web of Science ®Google Scholar
• Ryan JG, Masters SL, Booty MG, Habal N, Alexander JD, Barham BK, et al. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann Rheum Dis. 2010;69:1383–8.
   PubMed Web of Science ®Google Scholar
• Migita K, Uehara R, Nakamura Y, Yasunami M, Tsuchiya-Suzuki A, Yazaki M, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore). 2012;91:337–43.
   PubMed Web of Science ®Google Scholar
• Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, et al. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore). 2014;93:158–64.
   PubMed Web of Science ®Google Scholar
• Demirkaya E, Acikel C, Hashkes P, Gattorno M, Gul A, Ozdogan H, et al. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis. 2016;75:1051–6.
   PubMed Web of Science ®Google Scholar
• Moradian MM, Sarkisian T, Ajrapetyan H, Avanesian N. Genotype–phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet. 2010;55:389–93.
   PubMed Web of Science ®Google Scholar
• Perez-Hernandez J, Forner MJ, Pinto C, Chaves FJ, Cortes R, Redon J. Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus. PLoS One. 2015;10:e0138618.
   PubMed Web of Science ®Google Scholar
• Wu M, Barnard J, Kundu S, McCrae KR. A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles. J Thromb Haemost. 2015;13:1928–40.
   PubMed Web of Science ®Google Scholar
• Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G, et al. First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One. 2013;8:e73443.
   PubMed Web of Science ®Google Scholar
• Kamiya Y, Kawada J, Kawano Y, Torii Y, Kawabe S, Iwata N, et al. Serum microRNAs as potential biomarkers of juvenile idiopathic arthritis. Clin Rheumatol. 2015;34:1705–12.
   PubMed Web of Science ®Google Scholar
• Noren Hooten N, Fitzpatrick M, Wood WH, 3rd, De S, Ejiogu N, Zhang Y, et al. Age-related changes in microRNA levels in serum. Aging (Albany, NY). 2013;5:725–40.
   PubMedGoogle Scholar
• Koga T, Migita K, Sato S, Umeda M, Nonaka F, Kawashiri SY, et al. Multiple serum cytokine profiling to identify combinational diagnostic biomarkers in attacks of familial Mediterranean fever. Medicine (Baltimore). 2016;95:e3449.
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18:371–90.
   PubMed Web of Science ®Google Scholar
• Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the microRNA spectrum between serum and plasma. PLoS One. 2012;7:e41561.
   PubMed Web of Science ®Google Scholar
• Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol. 2011;14:159–67.
   PubMed Web of Science ®Google Scholar
• Tao L, Bei Y, Zhou Y, Xiao J, Li X. Non-coding RNAs in cardiac regeneration. Oncotarget. 2015;6:42613–22.
   PubMed Web of Science ®Google Scholar
• Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, et al. NOD2 is regulated by Mir-320 in physiological conditions but this control is altered in inflamed tissues of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:315–26.
   PubMed Web of Science ®Google Scholar